Predictors of early and late hepatocellular carcinoma recurrence.


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
28 Feb 2023
Historique:
received: 21 09 2022
revised: 06 01 2023
accepted: 30 01 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates are constantly increasing. Despite the availability of potentially curative treatments (liver transplantation, surgical resection, thermal ablation), long-term outcomes are affected by a high recurrence rate (up to 70% of cases 5 years after treatment). HCC recurrence within 2 years of treatment is defined as "early" and is generally caused by the occult intrahepatic spread of the primary neoplasm and related to the tumor burden. A recurrence that occurs after 2 years of treatment is defined as "late" and is related to de novo HCC, independent of the primary neoplasm. Early HCC recurrence has a significantly poorer prognosis and outcome than late recurrence. Different pathogenesis corresponds to different predictors of the risk of early or late recurrence. An adequate knowledge of predictive factors and recurrence risk stratification guides the therapeutic strategy and post-treatment surveillance. Patients at high risk of HCC recurrence should be referred to treatments with the lowest recurrence rate and when standardized to combined or adjuvant therapy regimens. This review aimed to expose the recurrence predictors and examine the differences between predictors of early and late recurrence.

Identifiants

pubmed: 36925456
doi: 10.3748/wjg.v29.i8.1243
pmc: PMC10011963
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1243-1260

Informations de copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: All authors report having no relevant conflicts of interest for this article.

Références

Liver Int. 2008 Mar;28(3):393-401
pubmed: 18028321
Biomed Pharmacother. 2017 Apr;88:395-402
pubmed: 28122304
J Hepatol. 2016 Oct;65(4):741-747
pubmed: 27388925
J Hepatol. 2017 Feb;66(2):363-373
pubmed: 27742377
Hepatoma Res. 2019;5:
pubmed: 31453368
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
J Surg Res. 2015 Sep;198(1):73-9
pubmed: 26022997
Cancer Control. 2018 Jan-Mar;25(1):1073274817744621
pubmed: 29327594
J Hepatocell Carcinoma. 2021 Jun 29;8:701-711
pubmed: 34235107
World J Hepatol. 2020 Sep 27;12(9):628-640
pubmed: 33033569
Front Oncol. 2022 May 24;12:876668
pubmed: 35686100
Hepatology. 2021 Feb;73(2):661-673
pubmed: 32324905
J Int Med Res. 2020 Aug;48(8):300060520945552
pubmed: 33106072
Cancers (Basel). 2021 May 08;13(9):
pubmed: 34066708
Oncologist. 2020 Oct;25(10):e1541-e1551
pubmed: 32472951
J Hepatol. 2003 Feb;38(2):200-7
pubmed: 12547409
J Hepatol. 2016 Oct;65(4):734-740
pubmed: 27288051
Hepatology. 2001 Jun;33(6):1394-403
pubmed: 11391528
J Hepatol. 2017 Dec;67(6):1204-1212
pubmed: 28802876
Liver Transpl. 2013 Jun;19(6):634-45
pubmed: 23536495
PLoS One. 2015 Apr 01;10(4):e0118658
pubmed: 25830231
World J Hepatol. 2019 Mar 27;11(3):261-272
pubmed: 30967904
Clin Gastroenterol Hepatol. 2007 Aug;5(8):938-45, 945.e1-4
pubmed: 17509946
Scand J Gastroenterol. 2015 May;50(5):567-76
pubmed: 25615260
Ann Surg. 2017 Oct;266(4):693-701
pubmed: 28650354
Asian Pac J Cancer Prev. 2014;15(16):6673-8
pubmed: 25169507
World J Gastroenterol. 2015 Jan 28;21(4):1207-15
pubmed: 25632194
J Immunol. 2006 Jun 15;176(12):7686-94
pubmed: 16751416
Am Surg. 2011 May;77(5):572-8
pubmed: 21679590
J Viral Hepat. 2022 Jan;29(1):26-34
pubmed: 34582610
Eur Radiol. 2021 May;31(5):3053-3064
pubmed: 33175203
Eur J Surg Oncol. 2012 Aug;38(8):683-91
pubmed: 22621971
J Gastroenterol Hepatol. 2012 Oct;27(10):1602-8
pubmed: 22554292
Lancet Oncol. 2015 Oct;16(13):1344-54
pubmed: 26361969
Gastroenterology. 2018 Jan;154(1):128-139
pubmed: 28989060
Oncology. 2007;72 Suppl 1:52-7
pubmed: 18087182
Int J Biol Markers. 2017 Oct 31;32(4):e370-e374
pubmed: 28561879
Ann Surg. 2006 Feb;243(2):229-35
pubmed: 16432356
J Hepatol. 2013 Apr;58(4):724-9
pubmed: 23178708
Hepatol Int. 2019 Mar;13(2):125-137
pubmed: 30600478
Sci China Life Sci. 2017 Jun;60(6):575-584
pubmed: 28547581
J Gastroenterol. 2021 Jan;56(1):90-100
pubmed: 33278003
J Hepatol. 2019 Aug;71(2):265-273
pubmed: 30959157
Transl Cancer Res. 2021 Mar;10(3):1261-1272
pubmed: 35116453
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):329-37
pubmed: 23460056
Hepatology. 2016 Dec;64(6):2077-2088
pubmed: 27178646
J Am Coll Surg. 2006 Feb;202(2):275-83
pubmed: 16427553
Gastroenterology. 2009 Sep;137(3):850-5
pubmed: 19524573
J Surg Oncol. 2017 Jun;115(8):971-979
pubmed: 28334430
HPB (Oxford). 2020 May;22(5):677-689
pubmed: 31607637
PLoS One. 2015 Jun 09;10(6):e0129000
pubmed: 26057656
Dig Dis Sci. 2019 Oct;64(10):3013-3019
pubmed: 30937719
Radiology. 2008 Jul;248(1):288-96
pubmed: 18483229
Ann Surg. 2017 Jul;266(1):118-125
pubmed: 27433914
Ann Surg Treat Res. 2018 Mar;94(3):129-134
pubmed: 29520346
J Am Coll Surg. 2017 Apr;224(4):610-621
pubmed: 28069527
World J Gastroenterol. 2019 Jun 7;25(21):2591-2602
pubmed: 31210712
Hepatology. 2016 Jul;64(1):106-16
pubmed: 26765068
Gut Liver. 2021 May 15;15(3):420-429
pubmed: 32839362
J Clin Oncol. 2015 Feb 20;33(6):550-8
pubmed: 25512453
Gut. 2018 Feb;67(2):362-371
pubmed: 27789659
J Hepatocell Carcinoma. 2021 May 20;8:435-450
pubmed: 34046368
Ann Gastroenterol. 2020 May-Jun;33(3):293-298
pubmed: 32382233
Liver Int. 2011 Jan;31(1):22-35
pubmed: 20874725
Ann Gastroenterol Surg. 2020 Feb 11;4(3):208-215
pubmed: 32490334
United European Gastroenterol J. 2019 Jun;7(5):699-708
pubmed: 31210948
J Hepatol. 2016 Oct;65(4):727-733
pubmed: 27349488
Clin Exp Hepatol. 2018 Sep;4(3):210-216
pubmed: 30324148
Lancet Oncol. 2020 Jul;21(7):947-956
pubmed: 32615109
JAMA Surg. 2014 Jun;149(6):519-27
pubmed: 24696192
J Viral Hepat. 2022 Jan;29(1):52-59
pubmed: 34695288
J Hepatol. 2009 Nov;51(5):890-7
pubmed: 19747749
JAMA Oncol. 2019 Jan 1;5(1):30-36
pubmed: 30267080
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1791-1799
pubmed: 28579181
Tumour Biol. 2017 Oct;39(10):1010428317720863
pubmed: 29034775
Gut. 2014 May;63(5):844-55
pubmed: 24531850
Gastroenterology. 2019 May;156(6):1683-1692.e1
pubmed: 30660729
Ann Surg Oncol. 2014 Jul;21(7):2429-35
pubmed: 24619495
J Hepatol. 2022 Mar;76(3):681-693
pubmed: 34801630
Liver Transpl. 2011 Oct;17 Suppl 2:S44-57
pubmed: 21695773
Am J Transplant. 2007 Nov;7(11):2587-96
pubmed: 17868066
Hepatology. 2018 Feb;67(2):600-611
pubmed: 28859220
BMC Gastroenterol. 2021 Nov 8;21(1):418
pubmed: 34749663
World J Gastroenterol. 2019 Jul 28;25(28):3704-3721
pubmed: 31391767
J Formos Med Assoc. 2021 Aug;120(8):1563-1571
pubmed: 33334659
N Engl J Med. 1996 Mar 14;334(11):693-9
pubmed: 8594428
Cancers (Basel). 2022 May 04;14(9):
pubmed: 35565424
Hepatology. 2022 Jul;76(1):9-11
pubmed: 35218241
Viruses. 2022 May 07;14(5):
pubmed: 35632728
Hepatology. 2017 Jun;65(6):2090-2099
pubmed: 28100008
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101459
pubmed: 32595103
World J Gastroenterol. 2015 Jul 7;21(25):7895-906
pubmed: 26167090
JAMA Surg. 2018 Oct 1;153(10):e182721
pubmed: 30073257
Transplantation. 2012 Sep 15;94(5):539-43
pubmed: 22864187
Adv Cancer Res. 2021;149:103-142
pubmed: 33579422
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Ann Surg. 2011 Jan;253(1):166-72
pubmed: 21294289
Eur J Gastroenterol Hepatol. 2012 Jul;24(7):849-56
pubmed: 22495400
HPB (Oxford). 2015 May;17(5):422-7
pubmed: 25421805
Liver Transpl. 2015 Sep;21(9):1142-52
pubmed: 25981135
Ann Surg. 2018 Dec;268(6):943-954
pubmed: 29521740
Ann Surg Oncol. 2012 Dec;19(13):4278-86
pubmed: 22752370
Cell Physiol Biochem. 2017;44(3):967-981
pubmed: 29179180
Pathol Res Pract. 2017 Jul;213(7):824-830
pubmed: 28554743
World J Gastroenterol. 2017 Feb 21;23(7):1139-1146
pubmed: 28275294
Dig Liver Dis. 2016 Nov;48(11):1275-1282
pubmed: 27481586
DNA Repair (Amst). 2019 May;77:76-86
pubmed: 30897375
Ann Hepatol. 2019 Nov - Dec;18(6):810-815
pubmed: 31543467
Transplant Proc. 2009 May;41(4):1260-3
pubmed: 19460533
Hepatology. 2016 Mar;63(3):839-49
pubmed: 26567038
World J Gastroenterol. 2014 Sep 28;20(36):12945-55
pubmed: 25278690
J Gastrointest Surg. 2019 Feb;23(2):304-311
pubmed: 30215196
Ann Surg. 2016 Mar;263(3):538-45
pubmed: 25775062
JAMA Surg. 2019 Mar 1;154(3):209-217
pubmed: 30422241
J Hepatol. 2012 Feb;56(2):412-8
pubmed: 21756858
Hepatology. 2015 Jun;61(6):1968-77
pubmed: 25689978
World J Hepatol. 2022 Jun 27;14(6):1190-1199
pubmed: 35978673
J Hepatol. 2019 Mar;70(3):440-448
pubmed: 30389551
Adv Cancer Res. 2021;149:1-61
pubmed: 33579421
Lancet Oncol. 2009 Jan;10(1):35-43
pubmed: 19058754
Am J Cancer Res. 2021 Jul 15;11(7):3711-3725
pubmed: 34354870
HPB (Oxford). 2013 Jul;15(7):504-10
pubmed: 23750492
BMC Cancer. 2021 Oct 29;21(1):1157
pubmed: 34715816
J Hepatol. 2016 Oct;65(4):719-726
pubmed: 27084592
J Hepatol. 2018 Mar;68(3):526-549
pubmed: 28989095
Gut. 2022 Mar;71(3):593-604
pubmed: 33741640
J Hepatol. 2019 Jan;70(1):78-86
pubmed: 30336183
J Hepatol. 2018 Dec;69(6):1284-1293
pubmed: 30236834
J Clin Med. 2021 Jan 11;10(2):
pubmed: 33440759
Aliment Pharmacol Ther. 2017 Oct;46(7):688-695
pubmed: 28791711
PLoS One. 2020 May 22;15(5):e0233212
pubmed: 32442193
Transplantation. 2018 May;102(5):816-822
pubmed: 29505494
Br J Surg. 2012 Dec;99(12):1622-9
pubmed: 23023956
Cancer. 2000 Aug 1;89(3):500-7
pubmed: 10931448
Infection. 2020 Feb;48(1):7-17
pubmed: 31347138
Transplant Proc. 2016 Jul-Aug;48(6):1968-77
pubmed: 27569930
Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1295-1307
pubmed: 34624198
Medicina (Kaunas). 2022 Feb 09;58(2):
pubmed: 35208582
Liver Transpl. 2018 Sep;24(9):1233-1242
pubmed: 29729113
J Am Coll Surg. 2015 Apr;220(4):416-27
pubmed: 25690672
Int J Surg. 2018 Aug;56:61-67
pubmed: 29723677
Adv Cancer Res. 2021;149:143-169
pubmed: 33579423

Auteurs

Riccardo Nevola (R)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.
Internal Medicine and Hepatology Unit, Ospedale Evangelico Betania, Naples 80147, Italy. riccardo.nevola@unicampania.it.

Rachele Ruocco (R)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Livio Criscuolo (L)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Angela Villani (A)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Maria Alfano (M)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Domenico Beccia (D)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Simona Imbriani (S)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Ernesto Claar (E)

Internal Medicine and Hepatology Unit, Ospedale Evangelico Betania, Naples 80147, Italy.

Domenico Cozzolino (D)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Ferdinando Carlo Sasso (FC)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Aldo Marrone (A)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Luigi Elio Adinolfi (LE)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Luca Rinaldi (L)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples 80138, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH